(19)
(11) EP 4 003 348 A1

(12)

(43) Date of publication:
01.06.2022 Bulletin 2022/22

(21) Application number: 20847742.2

(22) Date of filing: 29.07.2020
(51) International Patent Classification (IPC): 
A61K 31/454(2006.01)
C07D 401/12(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07D 221/18; C07D 405/04; C07D 407/04; C07D 311/76; C07D 471/06; C07D 491/16; C07D 491/06; C07D 491/052; C07D 401/04; A61K 45/06
(86) International application number:
PCT/US2020/044054
(87) International publication number:
WO 2021/021922 (04.02.2021 Gazette 2021/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.07.2019 US 201962880494 P
30.07.2019 US 201962880594 P

(71) Applicant: Mayo Foundation for Medical Education and Research
Rochester, MN 55905 (US)

(72) Inventors:
  • TSCHUMPERLIN, Daniel J.
    Rochester, Minnesota 55906 (US)
  • HAAK, Andrew J.
    Rochester, Minnesota 55902 (US)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES